Delta variant
Delta Variant[edit | edit source]
The Delta variant (B.1.617.2) is a variant of the SARS-CoV-2 virus, which causes COVID-19. It was first identified in India in late 2020 and has since spread to many countries around the world. The Delta variant is known for its increased transmissibility and potential impact on vaccine effectiveness.
Virology[edit | edit source]
The Delta variant is characterized by several mutations in the spike protein of the virus, which may enhance its ability to infect human cells. Key mutations include L452R and T478K, which are thought to increase the virus's binding affinity to the ACE2 receptor on human cells.
Transmission[edit | edit source]
Studies have shown that the Delta variant is more transmissible than the original strain of SARS-CoV-2 and other variants such as the Alpha variant. This increased transmissibility is attributed to the variant's ability to replicate more efficiently in the upper respiratory tract, leading to higher viral loads in infected individuals.
Symptoms[edit | edit source]
The symptoms of infection with the Delta variant are similar to those of other COVID-19 variants, including fever, cough, and loss of taste or smell. However, some reports suggest that the Delta variant may cause more severe symptoms, particularly in unvaccinated individuals.
Vaccine Effectiveness[edit | edit source]
While vaccines remain effective against the Delta variant, there is evidence that their effectiveness is somewhat reduced compared to other variants. Studies indicate that two doses of mRNA vaccines, such as Pfizer-BioNTech and Moderna, provide strong protection against severe disease and hospitalization caused by the Delta variant.
Public Health Impact[edit | edit source]
The rapid spread of the Delta variant has led to increased cases and hospitalizations in many regions, prompting renewed public health measures such as mask mandates and social distancing. Vaccination campaigns have been intensified to curb the spread of the variant.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
